Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62024CN0444

Case C-444/24 P: Appeal brought on 21 June 2024 by Valeria Converso against the judgment of the General Court (Second Chamber) delivered on 24 April 2024 in Case T-357/23, Verla-Pharm Arzneimittel v EUIPO – Converso (Pherla)

OJ C, C/2024/6629, 11.11.2024, ELI: http://data.europa.eu/eli/C/2024/6629/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/C/2024/6629/oj

European flag

Official Journal
of the European Union

EN

C series

C/2024/6629

11.11.2024

Appeal brought on 21 June 2024 by Valeria Converso against the judgment of the General Court (Second Chamber) delivered on 24 April 2024 in Case T-357/23, Verla-Pharm Arzneimittel v EUIPO – Converso (Pherla)

(Case C-444/24 P)

(C/2024/6629)

Language of the case: English

Parties

Appellant: Valeria Converso (represented by: F. Musella, avvocato)

Other parties to the proceedings: Verla-Pharm Arzneimittel GmbH & Co. KG, European Union Intellectual Property Office (EUIPO)

By order of 4 October 2024, the Court of Justice (Chamber determining whether appeals may proceed) held that the appeal was not allowed to proceed and that the appellant should bear her own costs.

ELI: http://data.europa.eu/eli/C/2024/6629/oj

ISSN 1977-091X (electronic edition)

Top